#

Cure epilepsy – Catalyst award

Ends on 30 June 2021

The CURE Epilepsy Catalyst Award (2 years / $250,000) supports nimble development of data necessary to advance ideas toward larger commercialization funding opportunities and is not intended to replace those opportunities.

Please refer to the Request for Proposals for an overview of the priority areas, application instructions, and FAQs.

Eligibility

This award is available to independent researchers at or above the level of Assistant Professor (or equivalent) at universities and non-academic research institutions, including small biotechnology companies, that seek to develop new interventions for epilepsy. International applicants are welcome to apply.

Postdoctoral fellows may not apply for this award. All materials must be submitted in English.

Budget

Requests may be made for up to a total of $250,000 paid over 2 years. Funding requests may include salary support for the PI, technical staff and/or collaborators; supplies, animal costs, etc.; and travel to an epilepsy-related conference if the PI is presenting his/her CURE Epilepsy-funded research.  Limited equipment purchases that are required to complete goals will be considered. Indirect costs are not supported.

REQUEST FOR PROPOSALS   GRANT PROCESS

Activity Approximate Date
Open Call for Letters of Intent Tuesday, June 1, 2021
Letter of Intent Deadline Wednesday, June 30, 2021, 9 PM ET
Full Proposal Invitations Friday, August 6, 2021
Full Proposals Deadline Friday, September 10, 2021, 9 PM ET
Awardee Notification December 2021-January 2022
Anticipated Award Start Date March 2022